Angiopoietin-like 3 antibody rivocibart for homozygous familial hypercholesterolemia

28 August 2026 (16:15 - 16:30)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Trials: rewriting cardiovascular disease on gene and molecular therapies Lipid-Lowering Agents ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology